Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
06
2021
accepted:
02
03
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
6
5
2022
Statut:
epublish
Résumé
High coverage of antiretroviral therapy (ART) in people living with HIV (PLHIV) increases viral suppression at population level and may reduce incidence. Médecins sans Frontières, in collaboration with the South African Department of Health, has been working in Eshowe/Mbongolwane (KwaZulu Natal) since 2011 to increase access to quality HIV services. Five years after an initial survey, we conducted a second survey to measure progress in HIV diagnosis and viral suppression and to identify remaining gaps. A cross-sectional, population-based, stratified two-stage cluster survey was implemented in 2018, using the same design as in 2013. Consenting participants aged 15-59 years were interviewed and tested for HIV at home. Those HIV-positive were tested for HIV viral load (viral suppression defined as <1000 copies/mL). Overall, 3,278 individuals were included. The proportion of HIV-positive participants virally suppressed was 83.8% in 2018 compared to 57.1% in 2013 (p<0.001), with increases in all subpopulations. The largest gap remained in men aged 15-29 years, among whom viral suppression was 51.5%. Nevertheless, of the total unsuppressed participants, 60.3% were women, and 57.4% were individuals aged 30-59 years. Between 2013 and 2018, HIV-positive status awareness progressed from 75.2% to 89.9% and ART coverage among those aware from 70.4% to 93.8%, respectively. Among those on ART, 94.5% were virally suppressed in 2018. Viral suppression improved significantly from 2013 to 2018, in all age and gender groups of PLHIV. However, almost half of HIV-positive young men remained unsuppressed, while the majority of virally unsuppressed PLHIV were women and older adults. To continue lowering HIV transmission, specific strategies are needed to increase viral suppression in those groups.
Identifiants
pubmed: 35324923
doi: 10.1371/journal.pone.0265488
pii: PONE-D-21-20591
pmc: PMC8946728
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265488Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Trop Med Int Health. 2010 Dec;15(12):1413-20
pubmed: 20958897
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
Sao Paulo Med J. 2014 Dec;132(6):383
pubmed: 25351762
PLoS One. 2017 Oct 3;12(10):e0185699
pubmed: 28973035
BMC Public Health. 2018 Mar 2;18(1):303
pubmed: 29499668
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Bull Math Biol. 2010 Nov;72(8):2180-98
pubmed: 20349152
J Int Assoc Physicians AIDS Care (Chic). 2010 May-Jun;9(3):170-2
pubmed: 20530471
BMC Infect Dis. 2017 Sep 29;17(1):653
pubmed: 28969607
CMAJ. 2018 Nov 19;190(46):E1350-E1360
pubmed: 30455270
AIDS. 2017 Feb 20;31(4):545-552
pubmed: 28121668
Lancet. 2009 Jan 3;373(9657):48-57
pubmed: 19038438
BMC Infect Dis. 2009 Feb 18;9:19
pubmed: 19226452
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):411-418
pubmed: 27243903
Lancet HIV. 2017 Nov;4(11):e505-e513
pubmed: 28779855